New Key Statistics Module, Z-Score and F-Score
XCNQ:MDMA Key Ratios
Market Cap C$ M | 9.11 |
Enterprise Value C$ M | 9.07 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 6.33 |
Price/Sales | 6.33 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 1.00 |
EPS (TTM) C$ | -0.007 |
Beneish M-Score | 3.53 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -33.99 |
EV-to-EBITDA | -43.42 |
PEG | -- |
Shares Outstanding M | 95.94 |
Net Margin (%) | -47.31 |
Operating Margin % | -20.84 |
Pre-tax Margin (%) | -47.31 |
Quick Ratio | 0.59 |
Current Ratio | 0.60 |
ROA % (ttm) | -25.36 |
ROE % (ttm) | -41.29 |
ROIC % (ttm) | -13.47 |
Dividend Yield % | -- |
Altman Z-Score | 0.85 |
XCNQ:MDMA Number of Guru Trades
XCNQ:MDMA Volume of Guru Trades
Gurus Latest Trades with XCNQ:MDMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XCNQ:MDMA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pharmala Biotech Holdings Inc Insider Transactions
No Available Data